Trials / Unknown
UnknownNCT03017248
Low-dose Ketamine for Acute Pain in the Emergency Department
Benefit of the Association of Low Doses of Ketamine With Intravenous Morphine in the Treatment of Acute Severe Pain in Emergency Department
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 125 (actual)
- Sponsor
- Faculty of Medicine, Sousse · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to determine the efficacy and safety of low dose ketamine in association with IV morphine in the management of acute moderate to severe pain in emergency department. The investigators hypothesize that low dose ketamine will result in more effective pain control than morphine alone and will not be associated with an increase in adverse events.
Detailed description
Management of pain in the Emergency Department is challenging. Treatment of pain is most often accomplished by parenteral opioids analgesics. However, the use of opioids alone for pain control is often associated with inadequate analgesia and increased adverse events. Low-dose ketamine has been shown to improve pain perception and produce an opioid-sparing effect when given perioperatively. Its use in the ED may probably play a role in maximizing analgesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | ketamine |
| DRUG | Placebos | 0.9% normal saline |
| DRUG | Morphine | Morphine |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-06-01
- Completion
- 2017-03-01
- First posted
- 2017-01-11
- Last updated
- 2017-01-31
Locations
1 site across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT03017248. Inclusion in this directory is not an endorsement.